Release Date: 18/07/13 11:04 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 139.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%